このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

Mindfulness-Based Therapy for Chronic Low Back Pain in Office Workers

2026年5月29日 更新者:Merve Sevindi İmançer、Dokuz Eylul University

The Effect of Mindfulness-Based Therapies on Pain Severity in Office Workers With Non-Specific Chronic Low Back Pain: A Randomized Controlled Trial

This study evaluated whether a mindfulness-based therapy program could reduce pain severity in office workers with non-specific chronic low back pain.

The study included staff members of Dokuz Eylul University aged 20 to 59 years who had low back pain for at least three months and worked at a desk for more than four hours per day. Participants were randomly assigned to either a mindfulness-based therapy group or a control group.

The mindfulness-based therapy group attended online group sessions once a week for four weeks. The sessions included breathing awareness meditation, body scan meditation, self-compassion meditation, and chair yoga practices. Participants in the control group continued their usual medical care during the study period.

The primary outcome of the study was pain severity, assessed using the Visual Analogue Scale. Secondary outcomes included physical activity level, disability related to low back pain, anxiety symptoms, quality of life, and mindfulness level.

Participants were evaluated at baseline, Week 4 (end of intervention), Week 16 (3-month follow-up), and Week 28 (6-month follow-up).

調査の概要

研究の種類

介入

入学 (実際)

104

段階

  • 適用できない

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究場所

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

  • 大人

健康ボランティアの受け入れ

いいえ

説明

Inclusion Criteria:

  • Staff member of Dokuz Eylül University
  • Aged between 20 and 59 years
  • Willing to participate in the study
  • Having low back pain for at least 3 months
  • Working at a desk for more than 4 hours per day
  • Having access to an internet connection at home or at work
  • Having a computer and/or smartphone suitable for participating in online sessions and completing online forms

Exclusion Criteria:

  • Presence of an organic condition that could explain low back pain, such as lumbar disc herniation
  • Presence of an underlying rheumatological disease, such as ankylosing spondylitis or rheumatoid arthritis
  • Diagnosed psychiatric disorder
  • Alcohol or substance dependence
  • Current use of psychiatric medication
  • Pregnancy
  • Speech or hearing problems that could interfere with participation

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 主な目的:処理
  • 割り当て:ランダム化
  • 介入モデル:並列代入
  • マスキング:なし(オープンラベル)

武器と介入

参加者グループ / アーム
介入・治療
実験的:Mindfulness-Based Therapy Group
Participants in this arm received a four-week online mindfulness-based therapy program. The program consisted of weekly 60-90-minute group sessions delivered online in small groups of approximately 8-10 participants. The sessions included breathing awareness meditation, body scan meditation, self-compassion meditation, and chair yoga practices. Participants were also encouraged to practise breathing awareness and body scan exercises at home for 10-15 minutes daily and to record their practice using a mindfulness practice log.
The intervention was a four-week online mindfulness-based therapy program delivered in small groups of approximately 8-10 participants. Participants attended one 60-90-minute online group session per week. The program included breathing awareness meditation, body scan meditation, self-compassion meditation, and chair yoga practices adapted for office workers with non-specific chronic low back pain. Each session included a brief theoretical introduction, guided practice, participant reflection, and a question-and-answer section. Participants were encouraged to practise breathing awareness and body scan exercises at home for 10-15 minutes daily and to record their practice, thoughts, and emotions using a mindfulness practice log.
介入なし:Usual Care Control Group
Participants in this arm continued their usual medical care during the study period and did not receive the mindfulness-based therapy program during the active study phase. After completion of the six-month follow-up assessment, participants were provided with video and audio recordings and written materials introducing the mindfulness techniques used in the intervention group.

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
Change From Baseline in Pain Severity on the Visual Analogue Scale
時間枠:Baseline, Week 4 (end of intervention), Week 16 (3-month follow-up), and Week 28 (6-month follow-up)
Pain severity was assessed using the Visual Analogue Scale (VAS), a 0-100 scale in which higher scores indicate greater pain severity.
Baseline, Week 4 (end of intervention), Week 16 (3-month follow-up), and Week 28 (6-month follow-up)

二次結果の測定

結果測定
メジャーの説明
時間枠
Change From Baseline in Physical Activity Level on the International Physical Activity Questionnaire Short Form
時間枠:Baseline, Week 4 (end of intervention), Week 16 (3-month follow-up), and Week 28 (6-month follow-up)
Physical activity level was assessed using the International Physical Activity Questionnaire Short Form (IPAQ-SF). The questionnaire assesses walking, moderate-intensity activity, vigorous-intensity activity, and sitting time during the previous 7 days. Physical activity is reported as metabolic equivalent task minutes per week (MET-min/week). Higher MET-min/week values indicate higher physical activity levels.
Baseline, Week 4 (end of intervention), Week 16 (3-month follow-up), and Week 28 (6-month follow-up)
Change From Baseline in Low Back Pain-Related Disability on the Roland-Morris Disability Questionnaire
時間枠:Baseline, Week 4 (end of intervention), Week 16 (3-month follow-up), and Week 28 (6-month follow-up)
Low back pain-related functional disability was assessed using the Roland-Morris Disability Questionnaire (RMDQ). The questionnaire includes 24 items scored as 0 or 1, resulting in a total score ranging from 0 to 24. Higher scores indicate greater functional disability.
Baseline, Week 4 (end of intervention), Week 16 (3-month follow-up), and Week 28 (6-month follow-up)
Change From Baseline in Health-Related Quality of Life on the Short Form-36 Health Survey
時間枠:Baseline, Week 4 (end of intervention), Week 16 (3-month follow-up), and Week 28 (6-month follow-up)
Health-related quality of life was assessed using the Short Form-36 Health Survey (SF-36). The SF-36 evaluates multiple domains of health-related quality of life. Domain scores range from 0 to 100, with higher scores indicating better health status.
Baseline, Week 4 (end of intervention), Week 16 (3-month follow-up), and Week 28 (6-month follow-up)
Change From Baseline in Anxiety Symptoms on the Beck Anxiety Inventory
時間枠:Baseline, Week 4 (end of intervention), Week 16 (3-month follow-up), and Week 28 (6-month follow-up)
Anxiety symptoms were assessed using the Beck Anxiety Inventory (BAI). The scale includes 21 items, each scored from 0 to 3, resulting in a total score ranging from 0 to 63. Higher scores indicate greater anxiety symptom severity.
Baseline, Week 4 (end of intervention), Week 16 (3-month follow-up), and Week 28 (6-month follow-up)
Change From Baseline in Mindfulness Level on the Five Facet Mindfulness Questionnaire Short Form
時間枠:Baseline, Week 4 (end of intervention), Week 16 (3-month follow-up), and Week 28 (6-month follow-up)
Mindfulness level was assessed using the Five Facet Mindfulness Questionnaire Short Form (FFMQ-SF). The questionnaire evaluates five facets of mindfulness: observing, describing, acting with awareness, non-judging of inner experience, and non-reactivity to inner experience. Higher scores indicate higher mindfulness levels.
Baseline, Week 4 (end of intervention), Week 16 (3-month follow-up), and Week 28 (6-month follow-up)

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

スポンサー

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (実際)

2022年4月4日

一次修了 (実際)

2022年6月6日

研究の完了 (実際)

2023年1月23日

試験登録日

最初に提出

2026年5月24日

QC基準を満たした最初の提出物

2026年5月29日

最初の投稿 (実際)

2026年6月2日

学習記録の更新

投稿された最後の更新 (実際)

2026年6月2日

QC基準を満たした最後の更新が送信されました

2026年5月29日

最終確認日

2026年5月1日

詳しくは

本研究に関する用語

その他の研究ID番号

  • DEU-2021-27-08

個々の参加者データ (IPD) の計画

個々の参加者データ (IPD) を共有する予定はありますか?

いいえ

IPD プランの説明

No individual participant data will be shared. Only aggregate study results will be reported in publications and presentations.

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

購読する